Pluristem Therapeutics Inc. | Balance Sheet
Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
54,213.00
58,819.00
53,441.00
32,815.00
26,960.00
30,587
Total Accounts Receivable
-
2,263.00
2,508.00
2,481.00
1,174.00
847
Other Current Assets
872.00
905.00
919.00
300.00
882.00
602
Total Current Assets
55,085.00
61,987.00
56,868.00
35,596.00
29,016.00
32,036
Net Property, Plant & Equipment
11,866.00
10,823.00
10,173.00
9,216.00
7,277.00
5,678
Total Investments and Advances
421.00
304.00
360.00
363.00
403.00
383
Long-Term Note Receivable
-
-
790.00
-
-
-
Other Assets
944.00
909.00
754.00
766.00
838.00
863
Total Assets
68,316.00
74,023.00
68,945.00
45,941.00
37,534.00
38,960
Accounts Payable
2,837.00
3,465.00
3,268.00
2,705.00
1,966.00
Other Current Liabilities
3,084.00
3,932.00
2,915.00
3,070.00
3,448.00
Total Current Liabilities
5,921.00
7,397.00
6,183.00
5,775.00
5,414.00
Provision for Risks & Charges
-
-
859.00
910.00
940.00
Other Liabilities
4,929.00
4,503.00
2,970.00
1,100.00
929.00
Total Liabilities
10,850.00
11,900.00
10,012.00
7,785.00
7,283.00
Common Equity (Total)
57,466.00
62,123.00
58,933.00
38,156.00
30,251.00
Total Shareholders' Equity
57,466.00
62,123.00
58,933.00
38,156.00
30,251.00
Total Equity
57,466.00
62,123.00
58,933.00
38,156.00
30,251.00
Liabilities & Shareholders' Equity
68,316.00
74,023.00
68,945.00
45,941.00
37,534.00
About Pluristem Therapeutics
View Profile
